New embryonic stem cell lines have been approved for use in federally-funded research in the US. Of these 13 new lines, 11 were made by Harvard Stem Cell Institute's George Daley and the other two by Rockefeller University's Ali Brivanlou. Both researchers used private funds for that work.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.